What is the main business of Esti-Lab?

The main business activity of Esti-Lab focuses on manufacture of medical and dental instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 2, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Okólna 44, 42-218 Częstochowa.

Who is on the management board?

The management board consists of: Maciej Mirosław Orzechowski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

How much revenue was generated?

The company reported a revenue of $202 in 2022, which is a decrease of 96.8% compared to 2021.

Is the company profitable?

No, in 2022 the company reported a net loss of $537.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $706 in 2022, representing 96% of all operating expenses.

Esti-Labsp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2020-09-02

Share capital

5,000.00 PLN

Registered address

ul. Okólna 44, 42-218 Częstochowa, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 2 of 3 financial statements were filed late (the longest delay 275 days for 2022).

2023not filed
202215/04/2024
202130/09/2022
202030/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.

Industry · Manufacture of medical and dental instruments and supplies472 / 495

Top 95%

Division · Other manufacturing472 / 495

Top 95%

Sector · Manufacturing11,635 / 12,010

Top 97%

Voivodeship · Śląskie48,363 / 51,326

Top 94%

Country · Poland464,182 / 495,867

Top 94%

Results vs industry

Revenue

This companyUSD 201.88MedianUSD 287.80kAverageUSD 4.91m

Net profit

This companyUSD -536.64MedianUSD 12.23kAverageUSD 208.02k

Operating costs

This companyUSD 738.49MedianUSD 272.78kAverageUSD 4.49m

Assets

This companyUSD 5.21kMedianUSD 224.38kAverageUSD 5.76m

Industry

Authorized Representatives

Maciej Mirosław Orzechowski – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Magdalena Agnieszka Kaniowskaage 51	5	$135.06	10%
Rafał Arkadiusz Kaniowskiage 50	45	$1,215.56	90%

Rafał Arkadiusz Kaniowski and Magdalena Agnieszka Kaniowska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-09-09 to 2025-07-18.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Infimedsp. z o.o.	$5,587,133.78	infimed.pl
Emtel Śliwasp. k.	$3,712,517.07	emtel.com.pl
Fabryka Narzędzi Medycznych Chirmed Marcin Dynersp. k.	$3,002,531.61	chirmed.pl
Profildentsp. z o.o.	$1,479,140.15	profildent.pl
Cleardentsp. z o.o.	$215,241.85	cleardent.pl
Smart Labssp. z o.o.	$32,047.41	smart-labs.pl
Medintechsp. z o.o.	$16,560.95	medintech.pl
Telemedical InnovationsS.A.	$872.98	telemedicalinnovations.com
Dentioscansp. z o.o.	$118.24	dentioscan.pl
Mindhandsp. z o.o.	$0.78	mindhand.pl

Change history

Date	Event
2024-12-20	Business suspended
2024-12-07	Business resumed
2022-12-06	Business suspended
2020-09-02	Entered in the register

FAQ

Last updated: 2026-04-21